Would a fluoroscopically guided hip injection provide pain relief for a patient with a chronic iliopsoas tendon tear, hip joint chondrosis, labral degeneration, and athletic pubalgia?

Fluoroscopically Guided Hip Injection for Complex Hip Pathology

A fluoroscopically guided hip injection can provide diagnostic value and short-term pain relief (typically 1-2 weeks) for your complex hip pathology, but therapeutic benefit is limited and should not be expected to provide sustained improvement given the combination of intra-articular and extra-articular pathology present.

Diagnostic vs. Therapeutic Value

Intra-articular Hip Injection

For the intra-articular pathology (chondrosis and labral degeneration):

• Intra-articular corticosteroid injections are recommended for hip osteoarthritis and can provide short-term pain relief 1
• Image guidance is mandatory for hip injections due to joint depth and proximity to neurovascular structures 1
• However, in patients with FAI, labral tears, and chondral lesions, therapeutic benefit is severely limited—only 37% of patients report clinically significant pain reduction at 14 days, and only 6% at 6 weeks, with average pain relief duration of just 9.8 days 2
• Interestingly, patients with chondral damage actually had greater relief from injection than those without, regardless of severity 3
• The diagnostic value (using anesthetic) is more reliable than therapeutic value—an intra-articular injection can help confirm whether hip joint pathology is contributing to pain 1

Iliopsoas Injection

For the chronic iliopsoas tendon tear:

• A separate iliopsoas bursa/peritendinous injection should be considered as this addresses extra-articular pathology that won't respond to intra-articular injection 1
• Fluoroscopy-guided iliopsoas bursa injection leads to relevant improvement at 1 month in 49% of patients, with significant pain reduction (mean NRS dropping from 5.9 to 3.5) 4
• A recent systematic review showed 71% of patients avoided surgery after iliopsoas injection, with Harris Hip Score improving from 58.49 to 89.91 5
• Iliopsoas injections are safe with no reported complications in systematic reviews 5

Athletic Pubalgia Considerations

For the athletic pubalgia component:

• This represents additional extra-articular pathology that will not be addressed by hip joint injection 1
• MRI is useful for evaluating athletic pubalgia, but injection therapy is not typically directed at this pathology 1

Practical Approach

Given your multiple pain generators, consider this algorithmic approach:

1. Start with fluoroscopically guided intra-articular hip injection with anesthetic ± corticosteroid 1

   • If >50% immediate pain relief during anesthetic phase: confirms intra-articular pathology as pain source 1
   • Therapeutic benefit from steroid will likely be short-lived (1-2 weeks) given your chondral and labral pathology 2

2. If anterior hip/groin pain persists, proceed with fluoroscopically guided iliopsoas bursa injection 1, 4

   • Use local anesthetic + corticosteroid combination 4, 5
   • Target the iliopsoas bursa using anterolateral approach 4
   • This addresses the chronic iliopsoas tear component specifically 5

3. Concurrent extra-articular pathology (iliopsoas, athletic pubalgia) does not alter interpretation of intra-articular injection results 3

Important Caveats

Limitations you should understand:

• Corticosteroid injections should be avoided for 3 months preceding any potential joint replacement surgery 1
• The amount of pain relief from diagnostic injection is a poor predictor of surgical outcomes if you proceed to hip arthroscopy 6
• With multiple overlapping pain generators (intra-articular chondrosis/labral pathology + iliopsoas tear + athletic pubalgia), isolating the primary pain source is challenging 1
• Diabetic patients should monitor glucose levels closely for 1-3 days post-injection due to transient hyperglycemia risk 1

Expected Outcomes

Realistic expectations based on evidence:

• Intra-articular injection: Expect minimal sustained therapeutic benefit beyond 2 weeks given your chondral and labral pathology 2
• Iliopsoas injection: 49% chance of clinically relevant improvement at 1 month; 71% may avoid surgery 4, 5
• Combined approach may be necessary given multiple pain generators, but each injection addresses different anatomic sources 1

The primary value of these injections in your case is diagnostic—to help determine which anatomic structure(s) are the dominant pain generators—rather than providing long-term therapeutic relief 1, 6.